Literature DB >> 1970609

Effects of YM-09151-2, a potent and selective dopamine D2 antagonist, on the ambulation-increasing effect of methamphetamine in mice.

H Kuribara1, S Tadokoro.   

Abstract

The ambulation-increasing effect of methamphetamine (2 mg/kg, s.c.) was markedly reduced by YM-09151-2 at 0.01 mg/kg, s.c., in drug-naive mice. The development of reverse tolerance to the ambulation-increasing effect of methamphetamine was also inhibited almost completely when 0.01 mg/kg, s.c., of YM-09151-2 was administered concomitantly in each administration. However, YM-09151-2, at 0.01 mg/kg, was partially suppressed the effect of methamphetamine in mice that exhibited reverse tolerance to methamphetamine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970609     DOI: 10.1254/jjp.52.489

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine.

Authors:  H Kuribara; T Asami; I Ida; Y Iijima; S Tadokoro
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum.

Authors:  Mitsuko Hamamura; Naotsugu Hirata; Kazuhiko Sawada; Takahide Shuto; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

3.  Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol.

Authors:  H Kuribara
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

4.  Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.

Authors:  H Kuribara
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.